Swanson Amy A, Pantanowitz Liron
Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota.
Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.
J Am Soc Cytopathol. 2024 Jan-Feb;13(1):10-15. doi: 10.1016/j.jasc.2023.09.007. Epub 2023 Sep 25.
There are few medical success stories in history as significant as the reduction in cervical cancer incidence. Through the collaborative efforts of dedicated scientific pioneers, the past century has witnessed remarkable advancement that began with the detection of exfoliated cancer cells through cytologic examination to widespread implementation of cervical cancer screening programs to the discovery of the link between cervical cancer and human papillomavirus (HPV). Current screening methods apply HPV-based testing, and artificial intelligence-based screening systems utilizing digitalized cytology images are being used in a continuous effort to optimize the accuracy and efficiency of the Papanicolaou test. This review summarizes the major milestones in cervical cancer screening history to emphasize its evolution as the World Health Organization aims for the global elimination of cervical cancer.
历史上很少有医学成功案例能像宫颈癌发病率的降低那样意义重大。在 dedicated scientific pioneers 的共同努力下,过去一个世纪见证了显著的进步,从通过细胞学检查发现脱落癌细胞,到广泛实施宫颈癌筛查项目,再到发现宫颈癌与人乳头瘤病毒(HPV)之间的联系。目前的筛查方法采用基于HPV的检测,利用数字化细胞学图像的基于人工智能的筛查系统也在不断应用,以努力优化巴氏试验的准确性和效率。本综述总结了宫颈癌筛查历史上的主要里程碑,以强调其演变,因为世界卫生组织旨在全球消除宫颈癌。